China · Delayed Price · Currency is CNY Youngy Health Statistics
Total Valuation
Youngy Health has a market cap or net worth of CNY 4.13 billion. The enterprise value is 3.80 billion.
| Market Cap | 4.13B |
| Enterprise Value | 3.80B |
Important Dates
The next estimated earnings date is Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Youngy Health has 804.04 million shares outstanding. The number of shares has decreased by -11.79% in one year.
| Current Share Class | 804.04M |
| Shares Outstanding | 804.04M |
| Shares Change (YoY) | -11.79% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 3.31% |
| Owned by Institutions (%) | 0.13% |
| Float | 620.54M |
Valuation Ratios
The trailing PE ratio is 52.17.
| PE Ratio | 52.17 |
| Forward PE | n/a |
| PS Ratio | 4.78 |
| PB Ratio | 3.36 |
| P/TBV Ratio | 3.79 |
| P/FCF Ratio | 60.64 |
| P/OCF Ratio | 53.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.13, with an EV/FCF ratio of 55.71.
| EV / Earnings | 49.34 |
| EV / Sales | 4.39 |
| EV / EBITDA | 24.13 |
| EV / EBIT | 31.09 |
| EV / FCF | 55.71 |
Financial Position
The company has a current ratio of 6.93, with a Debt / Equity ratio of 0.07.
| Current Ratio | 6.93 |
| Quick Ratio | 4.23 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.56 |
| Debt / FCF | 1.30 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.15% and return on invested capital (ROIC) is 13.69%.
| Return on Equity (ROE) | 9.15% |
| Return on Assets (ROA) | 5.57% |
| Return on Invested Capital (ROIC) | 13.69% |
| Return on Capital Employed (ROCE) | 9.16% |
| Weighted Average Cost of Capital (WACC) | 6.55% |
| Revenue Per Employee | 1.79M |
| Profits Per Employee | 158,983 |
| Employee Count | 484 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.89 |
Taxes
In the past 12 months, Youngy Health has paid 34.85 million in taxes.
| Income Tax | 34.85M |
| Effective Tax Rate | 24.50% |
Stock Price Statistics
The stock price has increased by +39.67% in the last 52 weeks. The beta is 0.44, so Youngy Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +39.67% |
| 50-Day Moving Average | 5.08 |
| 200-Day Moving Average | 4.40 |
| Relative Strength Index (RSI) | 41.90 |
| Average Volume (20 Days) | 30,613,857 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Youngy Health had revenue of CNY 864.89 million and earned 76.95 million in profits. Earnings per share was 0.10.
| Revenue | 864.89M |
| Gross Profit | 308.95M |
| Operating Income | 122.13M |
| Pretax Income | 142.27M |
| Net Income | 76.95M |
| EBITDA | 154.60M |
| EBIT | 122.13M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 524.76 million in cash and 88.78 million in debt, with a net cash position of 435.98 million or 0.54 per share.
| Cash & Cash Equivalents | 524.76M |
| Total Debt | 88.78M |
| Net Cash | 435.98M |
| Net Cash Per Share | 0.54 |
| Equity (Book Value) | 1.23B |
| Book Value Per Share | 1.41 |
| Working Capital | 887.51M |
Cash Flow
In the last 12 months, operating cash flow was 77.84 million and capital expenditures -9.68 million, giving a free cash flow of 68.15 million.
| Operating Cash Flow | 77.84M |
| Capital Expenditures | -9.68M |
| Free Cash Flow | 68.15M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 35.72%, with operating and profit margins of 14.12% and 8.90%.
| Gross Margin | 35.72% |
| Operating Margin | 14.12% |
| Pretax Margin | 16.45% |
| Profit Margin | 8.90% |
| EBITDA Margin | 17.88% |
| EBIT Margin | 14.12% |
| FCF Margin | 7.88% |
Dividends & Yields
Youngy Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.79% |
| Shareholder Yield | 11.79% |
| Earnings Yield | 1.86% |
| FCF Yield | 1.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 29, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Apr 29, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Youngy Health has an Altman Z-Score of 8.06 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.06 |
| Piotroski F-Score | 6 |